Corbus Pharmaceuticals Holdings, Inc. Investing Cash Flow
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Investing Cash Flow of $40.72 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06
- Corbus Pharmaceuticals Holdings, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $18.26M, a 2.91% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $22.45M, a 23.90% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$57.15M, a 754.58% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $19.64M.
- Corbus Pharmaceuticals Holdings, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$1.64M.
- Corbus Pharmaceuticals Holdings, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$121.31M, a 440.36% decline from fiscal 2023.
- Corbus Pharmaceuticals Holdings, Inc. net cash provided by (used in) investing activities for fiscal 2023 was $35.64M, a 18.51% increase from fiscal 2022.
- Corbus Pharmaceuticals Holdings, Inc. net cash provided by (used in) investing activities for fiscal 2022 was $30.07M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $18.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $40.72M 10-Q · filed 2026-08-06 | -$16.43M derived: sum of 3 quarters · filed 2026-08-06 | $3.21M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $22.45M 10-Q · filed 2026-05-12 | -$34.69M derived: sum of 2 quarters · filed 2026-05-12 | -$15.05M derived: sum of 3 quarters · filed 2026-05-12 | $2.69M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$57.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$37.51M derived: sum of 2 quarters · filed 2026-03-09 | -$19.76M derived: sum of 3 quarters · filed 2026-08-06 | -$1.64M 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | $19.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $37.38M derived: sum of 2 quarters · filed 2026-08-06 | $55.50M 10-Q · filed 2025-11-12 | $64.23M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $17.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $35.87M 10-Q · filed 2026-08-06 | $44.60M derived: sum of 3 quarters · filed 2026-08-06 | $29.23M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $18.12M 10-Q · filed 2026-05-12 | $26.85M derived: sum of 2 quarters · filed 2026-05-12 | $11.49M derived: sum of 3 quarters · filed 2026-05-12 | -$4.95M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $8.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$6.63M derived: sum of 2 quarters · filed 2026-03-09 | -$23.07M derived: sum of 3 quarters · filed 2026-03-09 | -$121.31M 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | -$15.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$31.80M derived: sum of 2 quarters · filed 2025-11-12 | -$130.04M 10-Q · filed 2025-11-12 | -$119.65M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | -$16.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$114.67M 10-Q · filed 2025-08-05 | -$104.29M derived: sum of 3 quarters · filed 2025-08-05 | -$93.39M derived: sum of 4 quarters · filed 2025-08-05 | ||||
| 2024-03-31 | -$98.24M 10-Q · filed 2025-05-06 | -$98.24M 10-Q · filed 2024-05-07 | -$87.85M derived: sum of 2 quarters · filed 2025-05-06 | -$76.95M derived: sum of 3 quarters · filed 2025-05-06 | -$68.14M derived: sum of 4 quarters · filed 2025-05-06 | |||
| 2023-12-31 | $10.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $21.29M derived: sum of 2 quarters · filed 2025-03-11 | $30.09M derived: sum of 3 quarters · filed 2025-03-11 | $35.64M 10-K · filed 2025-03-11 | $35.64M 10-K · filed 2024-03-12 | |||
| 2023-09-30 | $10.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $19.70M derived: sum of 2 quarters · filed 2024-11-07 | $25.25M 10-Q · filed 2024-11-07 | $25.25M 10-Q · filed 2023-11-07 | $37.03M derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | $8.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $14.36M 10-Q · filed 2024-08-06 | $14.36M 10-Q · filed 2023-08-08 | $26.14M derived: sum of 3 quarters · filed 2024-08-06 | $20.17M derived: sum of 4 quarters · filed 2024-08-06 | |||
| 2023-03-31 | $5.55M 10-Q · filed 2024-05-07 | $17.33M derived: sum of 2 quarters · filed 2024-05-07 | $11.36M derived: sum of 3 quarters · filed 2024-05-07 | -$7.34M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | $11.78M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $5.81M derived: sum of 2 quarters · filed 2024-03-12 | -$12.89M derived: sum of 3 quarters · filed 2024-03-12 | $30.07M 10-K · filed 2024-03-12 | ||||
| 2022-09-30 | -$5.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$24.67M derived: sum of 2 quarters · filed 2023-11-07 | $18.29M 10-Q · filed 2023-11-07 | $15.12M derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | -$18.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $24.27M 10-Q · filed 2023-08-08 | $21.09M derived: sum of 3 quarters · filed 2023-08-08 | $21.37M derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | $42.96M 10-Q · filed 2023-05-09 | $39.78M derived: sum of 2 quarters · filed 2023-05-09 | $40.07M derived: sum of 3 quarters · filed 2023-05-09 | $26.97M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | -$3.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -$2.89M derived: sum of 2 quarters · filed 2023-03-07 | -$15.99M derived: sum of 3 quarters · filed 2023-03-07 | -$73.42M 10-K · filed 2023-03-07 | ||||
| 2021-09-30 | $284.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$12.81M derived: sum of 2 quarters · filed 2022-11-08 | -$70.24M 10-Q · filed 2022-11-08 | -$70.19M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | -$13.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$70.52M 10-Q · filed 2022-08-09 | -$70.47M derived: sum of 3 quarters · filed 2022-08-09 | -$70.53M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$57.42M 10-Q · filed 2022-05-10 | -$57.37M derived: sum of 2 quarters · filed 2022-05-10 | -$57.43M derived: sum of 3 quarters · filed 2022-05-10 | -$57.45M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $52.09K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$4.71K derived: sum of 2 quarters · filed 2022-03-08 | -$20.89K derived: sum of 3 quarters · filed 2022-03-08 | -$484.49K 10-K · filed 2022-03-08 | ||||
| 2020-09-30 | -$56.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$72.97K derived: sum of 2 quarters · filed 2021-11-12 | -$536.58K 10-Q · filed 2021-11-12 | -$1.83M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | -$16.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$479.78K 10-Q · filed 2021-08-12 | -$1.77M derived: sum of 3 quarters · filed 2021-08-12 | -$2.97M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$463.61K 10-Q · filed 2021-05-13 | -$1.76M derived: sum of 2 quarters · filed 2021-05-13 | -$2.95M derived: sum of 3 quarters · filed 2021-05-13 | -$3.13M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | -$2.49M derived: sum of 2 quarters · filed 2021-03-15 | -$2.67M derived: sum of 3 quarters · filed 2021-03-15 | -$2.74M 10-K · filed 2021-03-15 | ||||
| 2019-09-30 | -$1.19M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-09 | -$1.38M derived: sum of 2 quarters · filed 2020-11-09 | -$1.45M 10-Q · filed 2020-11-09 | -$1.70M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | -$183.28K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-31 | -$256.90K 10-Q/A · filed 2020-08-31 | -$506.65K derived: sum of 3 quarters · filed 2020-08-31 | -$612.45K derived: sum of 4 quarters · filed 2020-08-31 | ||||
| 2019-03-31 | -$73.61K 10-Q · filed 2020-05-11 | -$323.37K derived: sum of 2 quarters · filed 2020-05-11 | -$429.17K derived: sum of 3 quarters · filed 2020-05-11 | -$1.10M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | -$249.75K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$355.55K derived: sum of 2 quarters · filed 2020-03-16 | -$1.03M derived: sum of 3 quarters · filed 2020-03-16 | -$2.30M 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | -$105.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$780.95K derived: sum of 2 quarters · filed 2019-11-07 | -$2.05M 10-Q · filed 2019-11-07 | -$2.63M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | -$675.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$1.94M 10-Q · filed 2019-08-08 | -$2.53M derived: sum of 3 quarters · filed 2019-08-08 | -$2.57M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | -$1.27M 10-Q · filed 2019-05-09 | -$1.85M derived: sum of 2 quarters · filed 2019-05-09 | -$1.90M derived: sum of 3 quarters · filed 2019-05-09 | |||||
| 2017-12-31 | -$580.18K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$625.61K derived: sum of 2 quarters · filed 2019-03-12 | -$707.43K 10-K · filed 2019-03-12 | |||||
| 2017-09-30 | -$45.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$127.25K 10-Q · filed 2018-11-08 | ||||||
| 2017-06-30 | -$81.82K 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |